About Osimertinib Tablet
Osimertinib TabletOsimertinib is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat non-small cell lung cancer.
- Medicine Name: Tagrisso
- Medicine Name: Osimertinib
- Company Name: AstraZeneca Pharmaceuticals LP
- Category : Lung Cancer
- Type : Allopathic/ Ayurvedic/ Homeopathic -
- Dosage Form :Oral
- Dose : 80mg And 40mg
- Packaging Size : 30 Tabs/Bottle
Key Application and BenefitOsimertinib is specifically used to treat adults with non-small cell lung cancer featuring the EGFR T790M mutation. Its targeted approach helps inhibit tumor progression, offering a critical benefit for patients experiencing resistance to prior EGFR therapy, thereby improving survival and symptom control.
How to Use and Recommended DosageOsimertinib tablets are intended for oral use only. Patients should take the medication exactly as prescribed by their physician, typically once per day. It is important not to crush or chew the tablets and to follow all medical advice to optimize effectiveness and minimize side effects.
Safety and Storage InstructionsKeep Osimertinib tablets in their original packaging and store them in a cool, dry environment. The tablets must not be used past their expiry date. Always keep out of reach of children and only take the medication under the supervision of an oncologist.
FAQs of Osimertinib Tablet:
Q: What is the primary use of Osimertinib Tablets?
A: Osimertinib Tablets are primarily used for the treatment of adults with non-small cell lung cancer (NSCLC) that tests positive for the EGFR T790M mutation. They help slow disease progression in patients who have developed resistance to previous EGFR-targeted therapies.
Q: How should I take Osimertinib Tablets?
A: Osimertinib should be taken orally once daily exactly as prescribed by your physician. Do not crush or split the tablet. Consistent timing each day helps maintain optimal drug levels in your body.
Q: When is Osimertinib prescribed and who can prescribe it?
A: Osimertinib is prescribed when NSCLC is found to have the EGFR T790M mutation, usually after resistance to earlier EGFR therapies. Only an oncologist can prescribe this medication after appropriate diagnostic testing.
Q: What precautions should I take while using Osimertinib?
A: Always follow your doctors guidelines. Inform your healthcare provider if you have any allergies, especially to Osimertinib or its components. This medication is not suitable for individuals with hypersensitivity to its ingredients.
Q: What are possible side effects of Osimertinib Tablets?
A: Common side effects may include diarrhea, rash, dry skin, nail toxicity, and fatigue. If you experience severe or persistent symptoms, contact your healthcare professional promptly.
Q: Where should Osimertinib Tablets be stored?
A: Store the tablets in a cool, dry place in their original packaging, away from direct sunlight and moisture. Always keep them out of the reach of children.